SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Enzo Biochem
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ralph Misitano who wrote (37)12/12/1996 12:13:00 AM
From: Bill German   of 83
 
Ralph, Here are some clues:
1. Last week the Dec 20 Calls were exploding
2. Last week the common volume increased over 200%
3. Even with the dow flurting with a correction, Enzo has
held steady.
4. It temporarily broke the $20. barrier
5. A lot of secrecy about the St.Lukes AIDS protocols, but
historically, the FDA issues an abundance of year end approvals
and "Human Clinical Trials" for Enzo's DNA could be one of them?
6. An upcoming partnership is almost certain, It could be
Boehringer but Baxter makes more sense.
7. D.H.Blair did the IPO (That alone, says a lot)
8. Buy the Jan 17.5 Calls and Good Luck......
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News